Department of Animal Sciences, University of Illinois, Urbana, Illinois, United States of America.
PLoS One. 2013;8(1):e53969. doi: 10.1371/journal.pone.0053969. Epub 2013 Jan 11.
Colonization of the gastrointestinal (GI) tract is initiated during birth and continually seeded from the individual's environment. Gastrointestinal microorganisms play a central role in developing and modulating host immune responses and have been the subject of investigation over the last decades. Animal studies have demonstrated the impact of GI tract microbiota on local gastrointestinal immune responses; however, the full spectrum of action of early gastrointestinal tract stimulation and subsequent modulation of systemic immune responses is poorly understood. This study explored the utility of an oral microbial inoculum as a therapeutic tool to affect porcine systemic immune responses. For this study a litter of 12 pigs was split into two groups. One group of pigs was inoculated with a non-pathogenic oral inoculum (modulated), while another group (control) was not. DNA extracted from nasal swabs and fecal samples collected throughout the study was sequenced to determine the effects of the oral inoculation on GI and respiratory microbial communities. The effects of GI microbial modulation on systemic immune responses were evaluated by experimentally infecting with the pathogen Mycoplasma hyopneumoniae. Coughing levels, pathology, toll-like receptors 2 and 6, and cytokine production were measured throughout the study. Sequencing results show a successful modulation of the GI and respiratory microbiomes through oral inoculation. Delayed type hypersensitivity responses were stronger (p = 0.07), and the average coughing levels and respiratory TNF-α variance were significantly lower in the modulated group (p<0.0001 and p = 0.0153, respectively). The M. hyopneumoniae infection study showed beneficial effects of the oral inoculum on systemic immune responses including antibody production, severity of infection and cytokine levels. These results suggest that an oral microbial inoculation can be used to modulate microbial communities, as well as have a beneficial effect on systemic immune responses as demonstrated with M. hyopneumoniae infection.
胃肠道(GI)定植始于出生,并持续从个体环境中获得定植。胃肠道微生物在宿主免疫反应的发展和调节中发挥核心作用,近几十年来一直是研究的主题。动物研究已经证明了 GI 道微生物群对局部胃肠道免疫反应的影响;然而,早期胃肠道刺激和随后全身免疫反应调节的全部作用范围还知之甚少。本研究探讨了口服微生物接种物作为影响猪全身免疫反应的治疗工具的效用。为此,将 12 头仔猪的一窝分为两组。一组猪接种了非致病性口服接种物(调节组),另一组(对照组)未接种。从整个研究过程中收集的鼻腔拭子和粪便样本中提取的 DNA 进行测序,以确定口服接种对 GI 和呼吸道微生物群落的影响。通过实验感染支原体肺炎来评估 GI 微生物调节对全身免疫反应的影响。在整个研究过程中,测量咳嗽水平、病理学、Toll 样受体 2 和 6 以及细胞因子产生。测序结果表明,口服接种成功地调节了 GI 和呼吸道微生物组。迟发型超敏反应更强(p=0.07),调节组的平均咳嗽水平和呼吸 TNF-α 方差显著降低(p<0.0001 和 p=0.0153,分别)。支原体肺炎感染研究表明,口服接种对全身免疫反应有有益影响,包括抗体产生、感染严重程度和细胞因子水平。这些结果表明,口服微生物接种可以用于调节微生物群落,并对支原体肺炎感染等全身免疫反应产生有益影响。